NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,757,714 | -2.5% | 27,074 | -3.4% | 0.08% | +19.0% |
Q2 2023 | $2,827,893 | +17.4% | 28,024 | +7.0% | 0.06% | -1.6% |
Q1 2023 | $2,409,548 | -0.1% | 26,191 | -1.5% | 0.06% | -5.9% |
Q4 2022 | $2,411,171 | +14.3% | 26,578 | -4.2% | 0.07% | +6.2% |
Q3 2022 | $2,110,000 | +13.8% | 27,749 | +26.6% | 0.06% | -17.9% |
Q2 2022 | $1,854,000 | -0.3% | 21,915 | +3.5% | 0.08% | +27.9% |
Q1 2022 | $1,859,000 | +3.9% | 21,166 | +3.5% | 0.06% | +17.3% |
Q4 2021 | $1,789,000 | -4.5% | 20,449 | -10.1% | 0.05% | -13.3% |
Q3 2021 | $1,873,000 | -10.0% | 22,755 | -0.4% | 0.06% | -11.8% |
Q2 2021 | $2,080,000 | +7.2% | 22,849 | +1.2% | 0.07% | -1.4% |
Q1 2021 | $1,941,000 | +174.5% | 22,587 | +202.7% | 0.07% | +81.6% |
Q4 2020 | $707,000 | -8.4% | 7,463 | -15.8% | 0.04% | -7.3% |
Q3 2020 | $772,000 | +37.9% | 8,864 | +38.5% | 0.04% | +10.8% |
Q2 2020 | $560,000 | +12.7% | 6,401 | +6.3% | 0.04% | -11.9% |
Q1 2020 | $497,000 | +14.0% | 6,019 | +30.8% | 0.04% | +13.5% |
Q4 2019 | $436,000 | +19.8% | 4,601 | +10.0% | 0.04% | +2.8% |
Q3 2019 | $364,000 | -22.1% | 4,181 | -18.0% | 0.04% | -29.4% |
Q2 2019 | $467,000 | -4.9% | 5,101 | +0.1% | 0.05% | -16.4% |
Q1 2019 | $491,000 | +20.9% | 5,098 | +8.0% | 0.06% | +5.2% |
Q4 2018 | $406,000 | +15.3% | 4,719 | +15.7% | 0.06% | +38.1% |
Q3 2018 | $352,000 | +47.9% | 4,078 | +29.7% | 0.04% | +35.5% |
Q2 2018 | $238,000 | -1.2% | 3,144 | +6.2% | 0.03% | -8.8% |
Q1 2018 | $241,000 | +12.1% | 2,961 | +16.8% | 0.03% | +17.2% |
Q4 2017 | $215,000 | -16.0% | 2,536 | -17.0% | 0.03% | -37.0% |
Q2 2017 | $256,000 | +9.9% | 3,056 | +4.5% | 0.05% | 0.0% |
Q3 2016 | $233,000 | -0.9% | 2,924 | +3.4% | 0.05% | -2.1% |
Q2 2016 | $235,000 | -42.7% | 2,828 | -50.0% | 0.05% | -50.5% |
Q1 2016 | $410,000 | -24.6% | 5,657 | -10.1% | 0.10% | -13.6% |
Q4 2015 | $544,000 | -18.1% | 6,294 | -12.5% | 0.11% | -31.2% |
Q3 2015 | $664,000 | -2.6% | 7,197 | +4.2% | 0.16% | -5.3% |
Q2 2015 | $682,000 | +19.4% | 6,910 | +19.3% | 0.17% | +21.6% |
Q1 2015 | $571,000 | -90.4% | 5,794 | -29.9% | 0.14% | +8.6% |
Q4 2014 | $5,972,000 | -99.3% | 8,269 | -7.2% | 0.13% | -32.3% |
Q2 2014 | $806,926,000 | +510612.7% | 8,913 | +379.7% | 0.19% | +293.8% |
Q1 2014 | $158,000 | – | 1,858 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |